Phase I/II study of adding intraperitoneal paclitaxel in patients with pancreatic cancer and peritoneal metastasis

BACKGROUND: Intraperitoneal chemotherapy using paclitaxel is considered an experimental approach for treating peritoneal carcinomatosis. This study aimed to determine the recommended dose, and to evaluate the clinical efficacy and safety, of the combination of intravenous gemcitabine, intravenous na...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:Br J Surg
Auteurs principaux: Yamada, S., Fujii, T., Yamamoto, T., Takami, H., Yoshioka, I., Yamaki, S., Sonohara, F., Shibuya, K., Motoi, F., Hirano, S., Murakami, Y., Inoue, H., Hayashi, M., Murotani, K., Kitayama, J., Ishikawa, H., Kodera, Y., Sekimoto, M., Satoi, S.
Format: Artigo
Langue:Inglês
Publié: John Wiley & Sons, Ltd. 2020
Sujets:
Original Articles
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC7689756/
https://ncbi.nlm.nih.gov/pubmed/32638367
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/bjs.11792
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires